Orgenesis Inc. Profile Avatar - Palmy Investing

Orgenesis Inc.

Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare t…

Biotechnology
US, Germantown [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Orgenesis Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of ORGS's Analysis
CIK: 1460602 CUSIP: 68619K204 ISIN: US68619K2042 LEI: - UEI: -
Secondary Listings
ORGS has no secondary listings inside our databases.